documents: FDA-2019-N-2175-0021
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-2175-0021 | FDA | FDA-2019-N-2175 | PRIA Reference 14 - Clinical Trials Transformation Initiative (CTTI). Use of Central IRBs for Multicenter Clinical Trials: Final Report. Available at: https://ctti-clinicaltrials.org/our-work/ethics-and-human-research-protection/single-irb, accessed June 7, 2022. RE Institutional Review Boards; Cooperative Research | Supporting & Related Material | Background Material | 2022-09-28T04:00:00Z | 2022 | 9 | 2022-09-28T19:30:38Z | 0 | 0 | 090000648537a893 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref